Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    9145719 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome
Condition: Von Hippel-Lindau Syndrome
Intervention: Drug: Ranibizumab
2 Completed EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome
Condition: Hippel-Lindau Disease
Intervention: Drug: EYE001
3 Completed Evaluation of Factors in Human Brain Tumors
Conditions: Brain Neoplasm;   Glioblastoma;   Glioma;   Pituitary Neoplasm
Intervention:

Indicates status has not been verified in more than two years